Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies

Authors

Néstor A. Molfino
Sandhia S Ponnarambil
Christopher Edward Brightling (ORCID: https://orcid.org/0000-0002-9345-4903)
Stephanie Korn (ORCID: https://orcid.org/0009-0001-2239-5029)
Ian Pavord (ORCID: https://orcid.org/0000-0002-4288-5973)
Christopher S. Ambrose (ORCID: https://orcid.org/0000-0003-4175-7336)
Nicole L. Martin
Jane R. Parnes

Institutions

AstraZeneca (United Kingdom) (GB)
Amgen (United States) (US)
AstraZeneca (South Korea) (KR)
Frauenklinik Heidelberg (DE)
Oxford BioMedica (United Kingdom) (GB)
AstraZeneca (Spain) (ES)
AstraZeneca (United States) (US)
NIHR Leicester Biomedical Research Centre (GB)

Publication Details

Journal: Pulmonary Therapy
Published: 2025-04-26
DOI: https://doi.org/10.1007/s41030-025-00294-2
Citations: 1
Primary Topic: Asthma and respiratory diseases
Type: article
Field-Weighted Citation Impact: 1.16

Funders

Amgen
AstraZeneca

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies

Néstor A. Molfino, Sandhia S Ponnarambil, Christopher Edward Brightling, Stephanie Korn et al.

Apr 26, 2025

1 citations

Pulmonary Therapy

Asthma and respiratory diseases

1.16

article

Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies

Néstor A. Molfino, Sandhia S Ponnarambil, Christopher Edward Brightling, Stephanie Korn, Ian Pavord, Christopher S. Ambrose, Nicole L. Martin, Jane R. Parnes

April 26, 2025article en

1 citations

Abstract

No abstract available for this paper.

Pulmonary TherapyVol. 11(2)

AstraZeneca (United Kingdom) (GB), Amgen (United States) (US), AstraZeneca (South Korea) (KR), Frauenklinik Heidelberg (DE), Oxford BioMedica (United Kingdom) (GB), AstraZeneca (Spain) (ES), AstraZeneca (United States) (US), NIHR Leicester Biomedical Research Centre (GB)

Amgen, AstraZeneca

Openalex Percentile: Top 23%

Asthma and respiratory diseases

1.16

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.